Target intelligence / Profile preview

TEN1-CDK3 readthrough (non-protein coding) (TEN1-CDK3)

Target
TEN1-CDK3
Molecular classification
Other (readthrough, non-coding RNA)
01

Overview

The TEN1-CDK3 readthrough locus is a naturally occurring transcript that spans the adjacent TEN1 and CDK3 genes on chromosome 17[1][3][7]. This transcript is classified as a candidate for nonsense-mediated mRNA decay and is generally not translated into a protein product. TEN1 by itself is a protein involved in the CST complex, which is essential for telomere end protection and length regulation, acting in concert with proteins such as STN1 and Cdc13[2][4][6]. However, the TEN1-CDK3 readthrough does not encode a functional protein and is not characterized as a molecular target for therapeutic intervention. If you require structured data about individual protein-coding genes (TEN1 or CDK3), each has well-documented functions: TEN1 is critical for telomere maintenance, whereas CDK3 is a cyclin-dependent kinase involved in cell cycle regulation[4][5][6]. This specific readthrough transcript is mostly considered a transcriptional byproduct with no established direct roles in molecular targeting or disease.

Other names
TEN1C17orf106C17orf106-CDK3TEN1-CDK3CST complex subunit TEN1Protein telomeric pathway with STN1 homologTelomere length regulation protein TEN1 homolog
02

Biological functions

Other (no direct protein function; the individual TEN1 gene is involved in telomere capping and length regulation, but the readthrough is not known to encode a functional protein[1][2][3][4].)
03

Disease associations

Other (no direct evidence for disease involvement from the readthrough; TEN1 is involved in telomere biology, which can be linked to diseases if mutated, but not specific to the readthrough[2][4][6].)

Beyond the preview

Go deeper on TEN1-CDK3 readthrough (non-protein coding) (TEN1-CDK3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TEN1-CDK3 readthrough (non-protein coding) (TEN1-CDK3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call